Page

Name

E-mail

Message

2025-04-01

#reports #VNRX

[VolitionRx Limited](https://eninvs.com/all.php?name=VNRX) (Diagnostics and Research) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182833)
(2025-03-31, After Market Close):

- Revenue -21.3% YoY (vs +187.9% in previous quarter and historical rate +130.7%)
- EBITDA margin -2857.3% increased compared to -3460.7% same period last year
- Net Debt increased by $2 bln since the start of the year (4035.6% of market cap)
- FCF (LTM) -$15.2 bln (negative), 30299.1% of market cap
- EV/Sales multiple is 1.2x

------------------------------------------------

2025-04-01

#reports #RHE

[Regional Health Properties](https://eninvs.com/all.php?name=RHE) (Medical Care Facilities) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182760)
(2025-04-03):

- Revenue +20% YoY (vs 0.0% in previous quarter and historical rate -3.1%)
- EBITDA margin 16.7% decreased compared to 20.0% same period last year
- Net Debt increased by $5 mln over the past reporting period (101887.3% of market cap)
- FCF (LTM) -$0 bln (negative), 81509.8% of market cap
- EV/EBITDA multiple is 17.5x compared to historical level (75th percentile) of 15x
- EV/Sales multiple is 1.9x

------------------------------------------------

2025-04-01

#reports #REKR

[Rekor Systems](https://eninvs.com/all.php?name=REKR) (Software — Infrastructure) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182793)
(2025-03-31, After Market Close):

- Revenue +18.2% YoY (vs +22.2% in previous quarter and historical rate +55.3%)
- EBITDA margin -138.5% decreased compared to -72.7% same period last year
- Net Debt increased by $6 mln over the past reporting period (13.6% of market cap)
- FCF (LTM) -$0 bln (negative), 9.1% of market cap
- EV/Sales multiple is 1.4x

------------------------------------------------

2025-04-01

#reports #PRGS

[Progress Software](https://eninvs.com/all.php?name=PRGS) (Software provider) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182758)
(2025-01-21, After Market Close):

- Revenue +28.6% YoY (vs +325.4% in previous quarter and historical rate +28.4%)
- EBITDA +14.5% YoY (vs +530.6% in previous quarter and historical rate +25.4%)
- EBITDA margin 29.8% decreased compared to 33.5% same period last year
- Net Debt decreased by $38 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) -$0.7 bln (negative), 30.5% of market cap
- EV/EBITDA multiple is 8.8x compared to historical level (75th percentile) of 15x
- EV/Sales multiple is 2.7x

At the opening of the session the share price went down -4.2% vs S&P500 +0.6%

------------------------------------------------

2025-04-01

#reports #POLA

[Polar Power](https://eninvs.com/all.php?name=POLA) (Electrical Equipment and Parts) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182783)
(2024-11-15, After Market Close):

- Revenue -25% YoY (vs +150.0% in previous quarter and historical rate +24.9%)
- EBITDA margin -100.0% decreased compared to -75.0% same period last year
- Net Debt decreased by $1 mln over the past reporting period (16.4% of market cap)
- EV/Sales multiple is 0.8x

At the opening of the session the share price went up +599.7% vs S&P500 +0.2%

------------------------------------------------

2025-04-01

#reports #POAI

[Predictive Oncology](https://eninvs.com/all.php?name=POAI) (Medical Instruments and Supplies) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182774)
(2023-05-17, After Market Close):

- Revenue +73.1% YoY (vs -51.6% in previous quarter and historical rate +77.9%)
- EBITDA margin -199.8% increased compared to -991.3% same period last year
- Net Debt increased by $2.4 bln since the start of the year (2142.3% of market cap)
- FCF (LTM) -$5.9 bln (negative), 5293.9% of market cap
- EV/Sales multiple is 0.1x

------------------------------------------------

2025-04-01

#reports #OVLY

[Oak Valley Bancorp](https://eninvs.com/all.php?name=OVLY) (Banks — Regional) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182773)
(2025-01-17, After Market Close):

- Revenue +5.9% YoY (vs 0.0% in previous quarter and historical rate +12.5%)
- Net Income 0% YoY (vs 0.0% in previous quarter and historical rate +38.7%)
- Net Income margin 44.4% decreased compared to 47.1% same period last year
- P/E multiple is 6.4x compared to historical level (75th percentile) of 7.4x
- P/S multiple is 2.9x
- Price to book: 1.1x

------------------------------------------------

2025-04-01

#reports #HCTI

[Healthcare Triangle, Inc.](https://eninvs.com/all.php?name=HCTI) (Health Information Services) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182808)
(2023-08-07):

- Revenue -71.4% YoY (vs -75.0% in previous quarter and historical rate -20.8%)
- Net Debt increased by $7 mln over the past reporting period (55.8% of market cap)
- FCF (LTM) +$0 bln (positive), 8.0% of market cap
- EV/Sales multiple is 2x

------------------------------------------------

2025-04-01

#reports #FTCI

[FTC Solar, Inc.](https://eninvs.com/all.php?name=FTCI) (Solar) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182805)
(2025-03-12, Before Market Open):

- Revenue -43.5% YoY (vs -67.7% in previous quarter and historical rate -32.8%)
- EBITDA margin -100.0% decreased compared to -47.8% same period last year
- Net Debt increased by $15 mln over the past reporting period (4.0% of market cap)
- FCF (LTM) -$0 bln (negative), 4.5% of market cap
- EV/Sales multiple is 8.1x

At the opening of the session the share price went up +5.9% vs S&P500 +0.9%

------------------------------------------------

2025-04-01

#reports #FBIOP

[Fortress Biotech](https://eninvs.com/all.php?name=FBIOP) (Biotechnology) reported for 2024 q4:

- Revenue -25% YoY (vs -57.1% in previous quarter and historical rate +7.9%)
- EBITDA margin -160.0% increased compared to -500.0% same period last year
- Net Debt increased by $16 mln over the past reporting period (13.5% of market cap)
- FCF (LTM) +$0 bln (positive), 7.6% of market cap
- EV/Sales multiple is 1.9x

------------------------------------------------

2025-04-01

#reports #BW

[Babcock & Wilcox Enterprises](https://eninvs.com/all.php?name=BW) (Specialty Industrial Machinery) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182750)
(2025-03-31, After Market Close):

- Revenue +269.2% YoY (vs -12.1% in previous quarter and historical rate +25.5%)
- EBITDA -250% YoY (vs -200.0% in previous quarter)
- EBITDA margin -0.7% decreased compared to 1.8% same period last year
- Net Debt increased by $139 mln over the past reporting period (232.8% of market cap)
- FCF (LTM) -$0 bln (negative), 63.7% of market cap
- EV/EBITDA multiple is 13.8x compared to historical level (75th percentile) of 55.6x
- EV/Sales multiple is 0.4x

------------------------------------------------

2025-03-29

#reports #FF

[FutureFuel](https://eninvs.com/all.php?name=FF) (Chemicals) reported for 2024 q4
(2024-11-08, After Market Close):

- Revenue -32.6% YoY (vs -56.4% in previous quarter and historical rate -1.0%)
- EBITDA -82.6% YoY (vs -133.3% in previous quarter)
- EBITDA margin 6.5% decreased compared to 25.0% same period last year
- Net Debt increased by $23 mln over the past reporting period (12.6% of market cap)
- FCF (LTM) -$0.1 bln (negative), 61.5% of market cap
- EV/EBITDA multiple is 5.5x compared to historical level (75th percentile) of 5.8x
- EV/Sales multiple is 0.3x

At the opening of the session the share price went down -9.5% vs S&P500 +0.2%

------------------------------------------------

2025-03-29

#reports #CLRO

[ClearOne](https://eninvs.com/all.php?name=CLRO) (Communication Equipment) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182690)
(2024-11-15, Before Market Open):

- Revenue -25% YoY (vs -40.0% in previous quarter and historical rate -23.0%)
- EBITDA margin -66.7% decreased compared to -50.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (6.9% of market cap)
- FCF (LTM) -$0 bln (negative), 130.8% of market cap
- EV/Sales multiple is 1.1x

At the opening of the session the share price went down -7.2% vs S&P500 -0.6%

------------------------------------------------

2025-03-29

#reports #CAAS

[China Automotive Systems](https://eninvs.com/all.php?name=CAAS) (Auto Parts) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182688)
(2025-03-28, Before Market Open):

- Revenue +18.9% YoY (vs +18.8% in previous quarter and historical rate +9.8%)
- EBITDA -26.3% YoY (vs +14.3% in previous quarter and historical rate +24.9%)
- EBITDA margin 7.4% decreased compared to 11.9% same period last year
- Net Debt decreased by $53 mln over the past reporting period (36.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 51.3% of market cap
- EV/EBITDA multiple is 0.8x compared to historical level (75th percentile) of 2.4x
- EV/Sales multiple is 0.1x

At the opening of the session the share price went up +1.0% vs S&P500 -0.2%

------------------------------------------------

2025-03-28

#reports #WHLM

[Wilhelmina International](https://eninvs.com/all.php?name=WHLM) (Specialty Business Services) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182637)
(2024-11-18, Before Market Open):

- Revenue 0% YoY (vs +25.0% in previous quarter and historical rate -15.4%)
- P/E multiple is 18x compared to historical level (75th percentile) of 23x
- P/S multiple is 1x
- Price to book: 0.7x

At the opening of the session the share price went down -0.6% vs S&P500 +0.2%

------------------------------------------------

2025-03-28

#reports #WGO

[Winnebago Industries](https://eninvs.com/all.php?name=WGO) (Motorhome manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182634)
(2025-03-27, Before Market Open):

- Revenue -57.7% YoY (vs -18.0% in previous quarter and historical rate +18.5%)
- EBITDA -87.3% YoY (vs -88.9% in previous quarter and historical rate -27.7%)
- EBITDA margin 2.1% decreased compared to 7.0% same period last year
- Net Debt increased by $39 mln over the past reporting period (3.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 10.4% of market cap
- EV/EBITDA multiple is 9.2x compared to historical level (75th percentile) of 6.8x
- EV/Sales multiple is 0.4x

At the opening of the session the share price went up +9.9% vs S&P500 -0.3%

------------------------------------------------

2025-03-28

#reports #SYPR

[Sypris Solutions](https://eninvs.com/all.php?name=SYPR) (Auto Parts) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182630)
(2025-03-24, Before Market Open):

- Revenue -5.7% YoY (vs +5.9% in previous quarter and historical rate +16.1%)
- EBITDA margin 6.1% increased compared to 2.9% same period last year
- Net Debt decreased by $2 mln over the past reporting period (5.6% of market cap)
- FCF (LTM) -$0 bln (negative), 5.6% of market cap
- EV/EBITDA multiple is 7x compared to historical level (75th percentile) of 12.7x
- EV/Sales multiple is 0.3x

At the opening of the session the share price went up +1.8% vs S&P500 +0.9%

------------------------------------------------

2025-03-28

#reports #PRPO

[Precipio](https://eninvs.com/all.php?name=PRPO) (Diagnostics and Research) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182639)
(2023-11-13, After Market Close):

- Revenue +25% YoY (vs 0.0% in previous quarter and historical rate +48.6%)
- EV/Sales multiple is 8.5x

At the opening of the session the share price went down -7.1%

------------------------------------------------

2025-03-28

#reports #MYSZ

[My Size](https://eninvs.com/all.php?name=MYSZ) (Software — Application) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182644)
(2022-11-17):

- Revenue -66.7% YoY (vs 0.0% in previous quarter and historical rate +94.4%)
- EBITDA margin -100.0% decreased compared to -66.7% same period last year
- Net Debt increased by $2 mln over the past reporting period (43.8% of market cap)
- FCF (LTM) -$0 bln (negative), 21.9% of market cap
- EV/Sales multiple is 0.3x

------------------------------------------------

2025-03-28

#reports #IRIX

[IRIDEX Corporation](https://eninvs.com/all.php?name=IRIX) (Medical Devices) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182623)
(2025-03-27, After Market Close):

- Revenue +8.3% YoY (vs -7.7% in previous quarter and historical rate -5.2%)
- Net Debt increased by $1 mln over the past reporting period (6.8% of market cap)
- FCF (LTM) -$0 bln (negative), 34.2% of market cap
- EV/Sales multiple is 0.3x

At the opening of the session the share price went up +16.1% vs S&P500 -0.2%

------------------------------------------------

2025-03-28

#reports #HQI

[HireQuest](https://eninvs.com/all.php?name=HQI) (Staffing and Employment Services) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182622)
(2025-03-27, After Market Close):

- Revenue -20% YoY (vs 0.0% in previous quarter and historical rate +20.3%)
- EBITDA 0% YoY (vs -166.7% in previous quarter and historical rate -9.8%)
- EBITDA margin 37.5% increased compared to 30.0% same period last year
- Net Debt decreased by $7 mln over the past reporting period (3.8% of market cap)
- FCF (LTM) +$0 bln (positive), 0.5% of market cap
- EV/EBITDA multiple is 25.3x compared to historical level (75th percentile) of 16.3x
- EV/Sales multiple is 5.6x

At the opening of the session the share price went down -6.9% vs S&P500 -0.2%

------------------------------------------------

2025-03-28

#reports #FEMY

[Femasys Inc.](https://eninvs.com/all.php?name=FEMY) (Medical Instruments and Supplies) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182619)
(2025-03-27, Before Market Open):

- Revenue +52% YoY (vs +127.5% in previous quarter and historical rate +56.2%)
- EBITDA margin -1073.5% increased compared to -1308.3% same period last year
- Net Debt increased by $4.4 bln since the start of the year (27677.1% of market cap)
- FCF (LTM) -$14.6 bln (negative), 92834.0% of market cap
- EV/Sales multiple is 1.5x

At the opening of the session the share price went down -4.6% vs S&P500 -0.3%

------------------------------------------------

2025-03-28

#reports #BKTI

[BK Technologies Corporation](https://eninvs.com/all.php?name=BKTI) (Communication Equipment) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182676)
(2023-05-11, Before Market Open):

- Revenue +12.5% YoY (vs 0.0% in previous quarter and historical rate +29.1%)
- EBITDA margin 16.7% increased compared to 6.3% same period last year
- Net Debt decreased by $3 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0 bln (positive), 1.5% of market cap
- EV/EBITDA multiple is 64.5x compared to historical level (75th percentile) of 188x
- EV/Sales multiple is 7.1x

At the opening of the session the share price went down -2.2%

------------------------------------------------

2025-03-28

#reports #AWH

[Aspira Women's Health](https://eninvs.com/all.php?name=AWH) (Treatments for gynecological problems developer ) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182682)
(2023-08-14, Before Market Open):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +8.3%)
- EBITDA margin -100.0% increased compared to -150.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (98.4% of market cap)
- FCF (LTM) +$0 bln (positive), 98.4% of market cap
- EV/Sales multiple is 0.4x

At the opening of the session the share price went up +0.6%

------------------------------------------------

2025-03-28

#reports #ABUS

[Arbutus Biopharma Corporation](https://eninvs.com/all.php?name=ABUS) (Biotechnology) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182614)
(2025-03-24, Before Market Open):

- Revenue +150% YoY (vs -80.0% in previous quarter and historical rate +30.4%)
- EBITDA margin -1100.0% increased compared to -3500.0% same period last year
- Net Debt increased by $8 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) -$0 bln (negative), 0.4% of market cap
- EV/Sales multiple is 34.3x

------------------------------------------------

2025-03-27

#reports #WOOF

[Petco Health and Wellness Company, Inc.](https://eninvs.com/all.php?name=WOOF) (Specialty Retail) reported for 2024 q4
(2025-03-26, After Market Close):

- Revenue -7.3% YoY (vs +1.1% in previous quarter and historical rate +1.8%)
- EBITDA +30.8% YoY (vs +5300.0% in previous quarter and historical rate -16.8%)
- EBITDA margin 4.4% increased compared to 3.1% same period last year
- Net Debt decreased by $109 mln over the past reporting period (16.3% of market cap)
- FCF (LTM) -$0 bln (negative), 0.9% of market cap
- EV/EBITDA multiple is 16.6x compared to historical level (75th percentile) of 16x
- EV/Sales multiple is 0.6x

------------------------------------------------

2025-03-27

#reports #VRNT

[Verint Systems](https://eninvs.com/all.php?name=VRNT) (Software developer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182579)
(2025-03-26, After Market Close):

- Revenue -4.2% YoY (vs +2.3% in previous quarter and historical rate +1.4%)
- EBITDA +40.5% YoY (vs -32.5% in previous quarter and historical rate +14.3%)
- EBITDA margin 23.2% increased compared to 15.8% same period last year
- Net Debt increased by $664 mln over the past reporting period (49.4% of market cap)
- EV/EBITDA multiple is 13x compared to historical level (75th percentile) of 27.6x
- EV/Sales multiple is 2.2x

------------------------------------------------

2025-03-27

#reports #VBFC

[Village Bank and Trust Financial](https://eninvs.com/all.php?name=VBFC) (Banks — Regional) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182587)
(2025-01-29, After Market Close):

- Revenue 0% YoY (vs +16.7% in previous quarter and historical rate -5.9%)
- Net Income -50% YoY (vs +100.0% in previous quarter and historical rate -11.8%)
- Net Income margin 14.3% decreased compared to 28.6% same period last year
- P/E multiple is 11.7x compared to historical level (75th percentile) of 14.2x
- P/S multiple is 4.3x
- Price to book: 1.6x

At the opening of the session the share price went down -0.5% vs S&P500 +0.2%

------------------------------------------------

2025-03-27

#reports #TH

[Target Hospitality](https://eninvs.com/all.php?name=TH) (Oil and Gas Equipment and Services) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182578)
(2025-03-26, Before Market Open):

- Revenue -33.3% YoY (vs -34.9% in previous quarter and historical rate +21.2%)
- EBITDA -50% YoY (vs -62.8% in previous quarter and historical rate +44.3%)
- EBITDA margin 29.8% decreased compared to 39.7% same period last year
- Net Debt decreased by $191 mln over the past reporting period (29.2% of market cap)
- FCF (LTM) +$0.1 bln (positive), 15.0% of market cap
- EV/EBITDA multiple is 4.4x compared to historical level (75th percentile) of 7.4x
- EV/Sales multiple is 1.7x

At the opening of the session the share price went up +8.2% vs S&P500 -0.1%

------------------------------------------------

2025-03-27

#reports #SONX

[Sonendo, Inc.](https://eninvs.com/all.php?name=SONX) (Medical Devices) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182590)
(2025-03-19, After Market Close):

- Revenue +300% YoY (vs -20.0% in previous quarter and historical rate +5.1%)
- EBITDA margin -75.0% increased compared to -550.0% same period last year
- Net Debt increased by $4 mln over the past reporting period (2.5% of market cap)
- FCF (LTM) -$0 bln (negative), 5.5% of market cap
- EV/Sales multiple is 5.5x

------------------------------------------------

2025-03-27

#reports #OPTN

[OptiNose](https://eninvs.com/all.php?name=OPTN) (Drug Manufacturers — Specialty and Generic) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182576)
(2025-03-06, Before Market Open):

- Revenue +10% YoY (vs -60.8% in previous quarter and historical rate +10.3%)
- EBITDA margin 4.5% increased compared to -10.0% same period last year
- Net Debt decreased by $2 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0 bln (positive), 0.6% of market cap
- EV/Sales multiple is 21.3x

At the opening of the session the share price went up +0.7% vs S&P500 -1.0%

------------------------------------------------

2025-03-27

#reports #MTEX

[Mannatech](https://eninvs.com/all.php?name=MTEX) (Household and Personal Products) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182581)
(2024-11-12, After Market Close):

- Revenue +284.8% YoY (vs -3.0% in previous quarter and historical rate +4.7%)
- EBITDA -100% YoY (vs 0.0% in previous quarter)
- Net Debt decreased by $1 mln over the past reporting period (5.7% of market cap)
- FCF (LTM) -$0 bln (negative), 11.4% of market cap
- EV/EBITDA multiple is 12.5x compared to historical level (75th percentile) of 2.6x
- EV/Sales multiple is 0.1x

At the opening of the session the share price went up +0.1% vs S&P500 -0.1%

------------------------------------------------

2025-03-27

#reports #IDN

[Intellicheck](https://eninvs.com/all.php?name=IDN) (Software — Application) reported for 2024 q4
(2025-03-20, After Market Close):

- Revenue +200% YoY (vs 0.0% in previous quarter and historical rate +24.4%)
- Net Debt increased by $1 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) -$0 bln (negative), 6.1% of market cap
- EV/Sales multiple is 1.5x

At the opening of the session the share price went up +13.7% vs S&P500 -0.6%

------------------------------------------------

2025-03-27

#reports #GTEC

[Greenland Technologies Corporation](https://eninvs.com/all.php?name=GTEC) (Specialty Industrial Machinery) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182570)
(2025-03-27, After Market Close):

- Revenue -17.4% YoY (vs -13.6% in previous quarter and historical rate -9.0%)
- EBITDA +33.3% YoY (vs -40.0% in previous quarter and historical rate +5.1%)
- EBITDA margin 21.1% increased compared to 13.0% same period last year
- Net Debt decreased by $14 mln over the past reporting period (78.6% of market cap)
- FCF (LTM) +$0 bln (positive), 44.9% of market cap
- EV/Sales multiple is -0.2x

------------------------------------------------

2025-03-27

#reports #DLTR

[Dollar Tree](https://eninvs.com/all.php?name=DLTR) (Store chain owner) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182572)
(2025-03-26, Before Market Open):

- Revenue -42.1% YoY (vs +3.5% in previous quarter and historical rate +2.4%)
- EBITDA margin 13.3% increased compared to -19.3% same period last year
- Net Debt decreased by $3.5 bln since the start of the year (22.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.9% of market cap
- EV/EBITDA multiple is 9.4x compared to historical level (75th percentile) of 17.9x
- EV/Sales multiple is 0.8x

At the opening of the session the share price went neutrally vs S&P500 -0.1%

------------------------------------------------

2025-03-27

#reports #DERM

[Journey Medical Corporation](https://eninvs.com/all.php?name=DERM) (Drug Manufacturers — Specialty and Generic) reported for 2024 q4
(2025-03-26, After Market Close):

- Revenue -6.7% YoY (vs -57.1% in previous quarter and historical rate -6.5%)
- EBITDA margin 14.3% increased compared to -240.0% same period last year
- Net Debt increased by $7 mln over the past reporting period (5.6% of market cap)
- FCF (LTM) -$0 bln (negative), 6.3% of market cap
- EV/Sales multiple is 2.3x

------------------------------------------------

2025-03-27

#reports #DDD

[3D Systems Corporation](https://eninvs.com/all.php?name=DDD) (3D printing services provider) reported for 2024 q4
(2025-03-26, After Market Close):

- Revenue -3.5% YoY (vs -8.9% in previous quarter and historical rate -10.5%)
- EBITDA margin -57.7% increased compared to -313.9% same period last year
- Net Debt increased by $21 mln over the past reporting period (5.8% of market cap)
- FCF (LTM) -$1.5 bln (negative), 429.8% of market cap
- EV/EBITDA multiple is 1.4x compared to historical level (75th percentile) of 2.7x
- EV/Sales multiple is 1.1x

------------------------------------------------

2025-03-27

#reports #ARTNA

[Artesian Resources Corporation](https://eninvs.com/all.php?name=ARTNA) (Utilities — Regulated Water) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182610)
(2025-03-24, After Market Close):

- Revenue +8% YoY (vs +7.4% in previous quarter and historical rate +5.6%)
- EBITDA 0% YoY (vs +20.0% in previous quarter and historical rate -2.4%)
- EBITDA margin 33.3% decreased compared to 36.0% same period last year
- Net Debt increased by $12 mln over the past reporting period (3.7% of market cap)
- FCF (LTM) +$0 bln (positive), 0.9% of market cap
- EV/EBITDA multiple is 13x compared to historical level (75th percentile) of 15x
- EV/Sales multiple is 4.7x

At the opening of the session the share price went up +0.3% vs S&P500 +0.1%

------------------------------------------------

2025-03-26

#reports #UNB

[Union Bankshares](https://eninvs.com/all.php?name=UNB) (Banks — Regional) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182563)
(2025-01-15, After Market Close):

- Revenue +11.1% YoY (vs 0.0% in previous quarter and historical rate -5.9%)
- Net Income -166.7% YoY (vs -100.0% in previous quarter)
- Net Income margin -40.0% decreased compared to 66.7% same period last year
- P/S multiple is 3.9x
- Price to book: 2x

At the opening of the session the share price went down -4.6% vs S&P500 +0.2%

------------------------------------------------

2025-03-26

#reports #SMTC

[Semtech](https://eninvs.com/all.php?name=SMTC) (Semiconductor manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182568)
(2025-03-13, After Market Close):

- Revenue +30.1% YoY (vs +17.9% in previous quarter and historical rate +7.9%)
- EBITDA margin 12.7% increased compared to -320.2% same period last year
- EV/EBITDA multiple is 23.6x compared to historical level (75th percentile) of 23.5x
- EV/Sales multiple is 3.3x

At the opening of the session the share price went up +13.9% vs S&P500 +0.8%

------------------------------------------------

2025-03-26

#reports #ISDR

[Issuer Direct Corporation](https://eninvs.com/all.php?name=ISDR) (Information Technology Services) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182567)
(2024-11-07, After Market Close):

- Revenue -87.5% YoY (vs -12.5% in previous quarter and historical rate +7.9%)
- EBITDA margin -1600.0% decreased compared to 12.5% same period last year
- Net Debt decreased by $1 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) +$0 bln (positive), 5.5% of market cap
- EV/Sales multiple is 2.1x

At the opening of the session the share price went down -2.1% vs S&P500 -0.1%

------------------------------------------------

2025-03-25

#reports #PMD

[Psychemedics Corporation](https://eninvs.com/all.php?name=PMD) (Diagnostics and Research) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182532)
(2024-11-12, After Market Close):

- Revenue -20% YoY (vs -16.7% in previous quarter and historical rate -8.0%)
- EV/Sales multiple is 0.6x

At the opening of the session the share price went down -0.6% vs S&P500 -0.1%

------------------------------------------------

2025-03-25

#reports #DBI

[Designer Brands](https://eninvs.com/all.php?name=DBI) (Apparel Retail) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182509)
(2025-03-20, Before Market Open):

- Revenue -5.3% YoY (vs -1.1% in previous quarter and historical rate +1.4%)
- EBITDA margin -1.4% increased compared to -4.8% same period last year
- Net Debt decreased by $58 mln over the past reporting period (19.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 21.1% of market cap
- EV/EBITDA multiple is 27.6x compared to historical level (75th percentile) of 28.2x
- EV/Sales multiple is 0.5x

At the opening of the session the share price went up +10.0% vs S&P500 -0.5%

------------------------------------------------

2025-03-25

#reports #BFIN

[BankFinancial Corporation](https://eninvs.com/all.php?name=BFIN) (Banks — Regional) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182500)
(2025-03-24, Before Market Open):

- Revenue 0% YoY (vs -7.7% in previous quarter and historical rate +1.1%)
- Net Income -200% YoY (vs 0.0% in previous quarter and historical rate -4.9%)
- Net Income margin -16.7% decreased compared to 16.7% same period last year
- P/E multiple is 39.8x compared to historical level (75th percentile) of 17.5x
- P/S multiple is 3.2x
- Price to book: 1x

At the opening of the session the share price went down -0.8% vs S&P500 +0.9%

------------------------------------------------

2025-03-22

#reports #SCHL

[Scholastic](https://eninvs.com/all.php?name=SCHL) (Educational products for children manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182493)
(2025-03-20, After Market Close):

- Revenue +3.4% YoY (vs -3.2% in previous quarter and historical rate +9.9%)
- EBITDA margin 0.9% increased compared to -3.7% same period last year
- EV/EBITDA multiple is 4.6x compared to historical level (75th percentile) of 8.4x
- EV/Sales multiple is 0.3x

At the opening of the session the share price went up +6.3% vs S&P500 -0.6%

------------------------------------------------

2025-03-22

#reports #AXDX

[Accelerate Diagnostics](https://eninvs.com/all.php?name=AXDX) (Diagnostics and Research) reported for 2024 q4
(2023-11-09, After Market Close):

- Revenue +200% YoY (vs 0.0% in previous quarter and historical rate +17.4%)
- EBITDA margin -133.3% increased compared to -333.3% same period last year
- Net Debt increased by $8 mln over the past reporting period (7.7% of market cap)
- FCF (LTM) -$0 bln (negative), 3.8% of market cap
- EV/Sales multiple is 8.9x

At the opening of the session the share price went down -2.4%

------------------------------------------------

2025-03-22

#reports #FORTY

[Formula Systems 1985](https://eninvs.com/all.php?name=FORTY) (Information Technology Services) reported for 2024 q4
(2024-11-20, Before Market Open):

- Revenue +8% YoY (vs +6.9% in previous quarter and historical rate +4.8%)
- EBITDA +85.7% YoY (vs +35.1% in previous quarter and historical rate +30.3%)
- EBITDA margin 3.8% increased compared to 2.2% same period last year
- Net Debt decreased by $88 mln over the past reporting period (6.1% of market cap)
- FCF (LTM) +$0.8 bln (positive), 54.0% of market cap
- EV/EBITDA multiple is 9.3x compared to historical level (75th percentile) of 14.7x
- EV/Sales multiple is 0.6x

------------------------------------------------

2025-03-21

#reports #TITN

[Titan Machinery](https://eninvs.com/all.php?name=TITN) (Industrial Distribution) reported for 2024 q4
(2025-03-20, Before Market Open):

- Revenue -10.8% YoY (vs -2.0% in previous quarter and historical rate +25.5%)
- EBITDA -173.5% YoY (vs -59.3% in previous quarter and historical rate +10.3%)
- EBITDA margin -4.7% decreased compared to 5.8% same period last year
- Net Debt increased by $164 mln over the past reporting period (43.6% of market cap)
- FCF (LTM) +$0 bln (positive), 0.5% of market cap
- EV/EBITDA multiple is 12.9x compared to historical level (75th percentile) of 5.2x
- EV/Sales multiple is 0.2x

At the opening of the session the share price went down -15.1% vs S&P500 -0.5%

------------------------------------------------

2025-03-21

#reports #TELA

[TELA Bio](https://eninvs.com/all.php?name=TELA) (Medical Devices) reported for 2024 q4
(2025-03-20, After Market Close):

- Revenue +5.9% YoY (vs +26.7% in previous quarter and historical rate +37.0%)
- EBITDA margin -44.4% increased compared to -70.6% same period last year
- Net Debt decreased by $35 mln over the past reporting period (60.5% of market cap)
- FCF (LTM) -$0 bln (negative), 50.2% of market cap
- EV/Sales multiple is 0.7x

------------------------------------------------

2025-03-21

#reports #SWKH

[SWK Corporation](https://eninvs.com/all.php?name=SWKH) (Asset Management) reported for 2024 q4
(2025-03-19, After Market Close):

- Revenue +20% YoY (vs +11.1% in previous quarter and historical rate +2.8%)
- P/E multiple is 15.4x compared to historical level (75th percentile) of 41.8x
- P/S multiple is 4.7x
- Price to book: 0.8x

At the opening of the session the share price went down -1.2% vs S&P500 -0.5%

------------------------------------------------

2025-03-21

#reports #RKDA

[Arcadia Biosciences](https://eninvs.com/all.php?name=RKDA) (Agricultural Inputs) reported for 2024 q4
(2023-08-10, After Market Close):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +16.0%)
- EBITDA margin 200.0% increased compared to -300.0% same period last year
- Net Debt increased by $2 mln over the past reporting period (101.1% of market cap)
- FCF (LTM) -$0 bln (negative), 151.7% of market cap
- EV/EBITDA multiple is 1.3x compared to historical level (75th percentile) of 0.9x
- EV/Sales multiple is -0.8x

At the opening of the session the share price went up +4.5%

------------------------------------------------

2025-03-21

#reports #DXLG

[Destination XL Group](https://eninvs.com/all.php?name=DXLG) (Apparel Retail) reported for 2024 q4
(2025-03-20, Before Market Open):

- Revenue -13.1% YoY (vs -9.2% in previous quarter and historical rate -2.1%)
- EBITDA -83.3% YoY (vs -11.1% in previous quarter and historical rate -5.2%)
- EBITDA margin 1.7% decreased compared to 8.8% same period last year
- Net Debt decreased by $2 mln over the past reporting period (1.9% of market cap)
- FCF (LTM) -$0 bln (negative), 14.2% of market cap
- EV/EBITDA multiple is 8.6x compared to historical level (75th percentile) of 8.1x
- EV/Sales multiple is 0.5x

At the opening of the session the share price went down -10.9% vs S&P500 -0.5%

------------------------------------------------

2025-03-21

#reports #BFRI

[Biofrontera Inc.](https://eninvs.com/all.php?name=BFRI) (Drug Manufacturers — Specialty and Generic) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182461)
(2023-08-11, Before Market Open):

- Revenue +8.8% YoY (vs 0.0% in previous quarter and historical rate +34.6%)
- EBITDA margin -45.9% increased compared to -67.6% same period last year
- EV/Sales multiple is 0.5x

At the opening of the session the share price went down -1.9%

------------------------------------------------

2025-03-21

#reports #BBGI

[Beasley Broadcast Group](https://eninvs.com/all.php?name=BBGI) (Broadcasting) reported for 2024 q4
(2024-11-05, Before Market Open):

- Revenue +2.3% YoY (vs -3.2% in previous quarter and historical rate +31.6%)
- EBITDA -4.1% YoY (vs +235300.0% in previous quarter and historical rate +44.7%)
- EBITDA margin 13.9% decreased compared to 14.9% same period last year
- Net Debt decreased by $275.3 bln since the start of the year (148943.3% of market cap)
- FCF (LTM) +$1.8 bln (positive), 988.3% of market cap
- EV/EBITDA multiple is 13.6x compared to historical level (75th percentile) of 13.3x
- EV/Sales multiple is 1.1x

At the opening of the session the share price went down -3.0% vs S&P500 +0.1%

------------------------------------------------

2025-03-21

#reports #ARL

[American Realty Investors](https://eninvs.com/all.php?name=ARL) (Real Estate — Development) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182440)
(2024-03-22, Before Market Open):

- Revenue +157.1% YoY (vs -7.7% in previous quarter and historical rate +23.6%)
- EBITDA -162.5% YoY (vs -50.0% in previous quarter)
- EBITDA margin -13.9% decreased compared to 57.1% same period last year
- EV/Sales multiple is 3.4x

At the opening of the session the share price went down -6.0% vs S&P500 0.0%

------------------------------------------------

2025-03-21

#reports #YI
@ china

[Yi Technology](https://eninvs.com/all.php?name=YI) (Pharmaceutical Retailers) reported for 2024 q4
(2025-03-13, Before Market Open):

- Revenue -9% YoY (vs +2.2% in previous quarter and historical rate +2.9%)
- EBITDA margin 4.6% increased compared to -0.7% same period last year
- Net Debt increased by $24 mln over the past reporting period (2.8% of market cap)
- FCF (LTM) -$0 bln (negative), 3.0% of market cap
- EV/Sales multiple is 0.5x

At the opening of the session the share price went up +2.3% vs S&P500 -0.1%

------------------------------------------------

2025-03-21

#reports #BZUN
@ china

[Baozun](https://eninvs.com/all.php?name=BZUN) ( E-commerce solutions provider) reported for 2024 q4
(2025-03-20, Before Market Open):

- Revenue +4.6% YoY (vs +17.2% in previous quarter and historical rate -1.0%)
- EBITDA margin 2.4% increased compared to 0.3% same period last year
- Net Debt decreased by $32 mln over the past reporting period (15.2% of market cap)
- FCF (LTM) +$0.4 bln (positive), 171.0% of market cap
- EV/Sales multiple is 0.2x

At the opening of the session the share price went down -4.6% vs S&P500 -0.5%

------------------------------------------------

2025-03-20

#reports #WSM

[Williams-Sonoma](https://eninvs.com/all.php?name=WSM) (Household goods supplier) reported for 2024 q4
(2025-03-19, Before Market Open):

- Revenue +8% YoY (vs -2.9% in previous quarter and historical rate -2.0%)
- EBITDA +12% YoY (vs +2.4% in previous quarter and historical rate +7.1%)
- EBITDA margin 23.9% increased compared to 23.0% same period last year
- Net Debt decreased by $355 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) -$0.3 bln (negative), 1.2% of market cap
- EV/EBITDA multiple is 12.4x compared to historical level (75th percentile) of 8.9x
- EV/Sales multiple is 2.7x

At the opening of the session the share price went down -8.4% vs S&P500 +0.3%

------------------------------------------------

2025-03-20

#reports #TISI

[Team](https://eninvs.com/all.php?name=TISI) (Specialty Business Services) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182415)
(2023-05-11, After Market Close):

- Revenue -0.5% YoY (vs +1.9% in previous quarter and historical rate -0.7%)
- Net Income margin -3.3% increased compared to -10.7% same period last year
- P/S multiple is 0.1x
- Price to book: 3.4x

At the opening of the session the share price went down -0.2%

------------------------------------------------

2025-03-20

#reports #ICAD

[iCAD](https://eninvs.com/all.php?name=ICAD) (Health Information Services) reported for 2024 q4
(2025-03-19, After Market Close):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate -16.9%)
- EBITDA margin -20.0% has not changed compared to -20.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) -$0 bln (negative), 4.8% of market cap
- EV/Sales multiple is 2.4x

------------------------------------------------

2025-03-19

#reports #ESLT

[Elbit Systems](https://eninvs.com/all.php?name=ESLT) (Aerospace and Defense) reported for 2024 q4
(2025-03-18, Before Market Open):

- Revenue +18.7% YoY (vs +14.4% in previous quarter and historical rate +9.3%)
- EBITDA +67.9% YoY (vs +10.7% in previous quarter and historical rate +6.7%)
- EBITDA margin 9.5% increased compared to 6.7% same period last year
- Net Debt decreased by $375 mln over the past reporting period (2.1% of market cap)
- FCF (LTM) -$0.2 bln (negative), 1.2% of market cap
- EV/EBITDA multiple is 29.7x compared to historical level (75th percentile) of 19.3x
- EV/Sales multiple is 2.8x

At the opening of the session the share price went up +7.2% vs S&P500 -0.4%

------------------------------------------------

2025-03-19

#reports #HUYA
@ china , @ gaming

[HUYA](https://eninvs.com/all.php?name=HUYA) (Entertainment) reported for 2024 q4
(2025-03-18, Before Market Open):

- Revenue -4.7% YoY (vs -3.1% in previous quarter and historical rate -19.6%)
- EBITDA margin 0.5% increased compared to -14.4% same period last year
- Net Debt increased by $214 mln over the past reporting period (24.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 11.1% of market cap
- EV/EBITDA multiple is 2.8x compared to historical level (75th percentile) of 3.1x
- EV/Sales multiple is 0.2x

At the opening of the session the share price went down -5.3% vs S&P500 -0.4%

------------------------------------------------

2025-03-19

#reports #XPEV
@ china , @ electric-vehicles

[XPeng](https://eninvs.com/all.php?name=XPEV) (Auto Manufacturers) reported for 2024 q4
(2025-03-18, Before Market Open):

- Revenue +20% YoY (vs +23.1% in previous quarter and historical rate +36.4%)
- EBITDA margin -2.4% increased compared to -5.2% same period last year
- Net Debt decreased by $90 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) -$5.7 bln (negative), 14.7% of market cap
- EV/Sales multiple is 6.9x

At the opening of the session the share price went down -5.0% vs S&P500 -0.4%

------------------------------------------------

2025-03-19

#reports #XBIO

[Xenetic Biosciences](https://eninvs.com/all.php?name=XBIO) (Biotechnology) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182385)
(2023-08-11, Before Market Open):

- Revenue -3.4% YoY (vs +0.5% in previous quarter and historical rate +77.9%)
- EBITDA margin -169.3% increased compared to -419.5% same period last year
- Net Debt increased by $674 mln over the past reporting period (12635.1% of market cap)
- FCF (LTM) -$2.1 bln (negative), 40173.5% of market cap
- EV/EBITDA multiple is 4.2x compared to historical level (75th percentile) of 4.7x
- EV/Sales multiple is -2.5x

At the opening of the session the share price went up +6.9%

------------------------------------------------

2025-03-19

#reports #MRVI

[Maravai LifeSciences Holdings, Inc.](https://eninvs.com/all.php?name=MRVI) (Biotechnology) reported for 2024 q4
(2025-03-18, After Market Close):

- Revenue -23% YoY (vs -3.0% in previous quarter and historical rate -20.6%)
- EBITDA margin -189.5% decreased compared to -104.1% same period last year
- EV/Sales multiple is 1.4x

------------------------------------------------

2025-03-19

#reports #ETON

[Eton Pharmaceuticals](https://eninvs.com/all.php?name=ETON) (Biotechnology) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182373)
(2025-03-18, Before Market Open):

- Revenue +71.4% YoY (vs +42.9% in previous quarter and historical rate +70.8%)
- EBITDA margin 8.3% increased compared to -28.6% same period last year
- Net Debt increased by $31 mln over the past reporting period (8.2% of market cap)
- EV/Sales multiple is 10.1x

At the opening of the session the share price went down -11.3% vs S&P500 -0.4%

------------------------------------------------

2025-03-18

#reports #WSR

[Whitestone REIT](https://eninvs.com/all.php?name=WSR) (REIT — Retail) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182327)
(2025-03-03, After Market Close):

- Revenue +7.9% YoY (vs +5.4% in previous quarter and historical rate +7.5%)
- EBITDA margin 56.1% increased compared to -18.4% same period last year
- EV/EBITDA multiple is 8.2x compared to historical level (75th percentile) of 23.5x
- EV/Sales multiple is 4.6x

At the opening of the session the share price went up +1.3% vs S&P500 -0.3%

------------------------------------------------

2025-03-18

#reports #TSQ

[Townsquare Media](https://eninvs.com/all.php?name=TSQ) (Advertising Agencies) reported for 2024 q4
(2025-03-17, Before Market Open):

- Revenue +2.6% YoY (vs 0.0% in previous quarter and historical rate +2.8%)
- EBITDA margin 26.3% increased compared to -2.6% same period last year
- Net Debt decreased by $9 mln over the past reporting period (6.8% of market cap)
- FCF (LTM) +$0 bln (positive), 1.5% of market cap
- EV/EBITDA multiple is 13.5x compared to historical level (75th percentile) of 50.6x
- EV/Sales multiple is 1.4x

At the opening of the session the share price went up +0.9% vs S&P500 -0.1%

------------------------------------------------

2025-03-18

#reports #NGS

[Natural Gas Services Group](https://eninvs.com/all.php?name=NGS) (Oil and Gas Equipment and Services) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182312)
(2025-03-17, After Market Close):

- Revenue +116.7% YoY (vs +32.3% in previous quarter and historical rate +39.4%)
- EBITDA +100% YoY (vs +108.3% in previous quarter and historical rate +68.8%)
- EBITDA margin 30.8% decreased compared to 33.3% same period last year
- Net Debt increased by $5 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) -$0 bln (negative), 0.7% of market cap
- EV/EBITDA multiple is 5.3x compared to historical level (75th percentile) of 8.9x
- EV/Sales multiple is 2.4x

At the opening of the session the share price went down -9.6% vs S&P500 -0.4%

------------------------------------------------

2025-03-18

#reports #KFS

[Kingsway Financial Services](https://eninvs.com/all.php?name=KFS) (Auto and Truck Dealerships) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182321)
(2024-11-06, After Market Close):

- Revenue +15.4% YoY (vs +8.0% in previous quarter and historical rate +9.3%)
- EBITDA +100% YoY (vs 0.0% in previous quarter)
- EBITDA margin 13.3% increased compared to 7.7% same period last year
- Net Debt increased by $3 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) -$0 bln (negative), 4.8% of market cap
- EV/EBITDA multiple is 21.2x compared to historical level (75th percentile) of 360x
- EV/Sales multiple is 1.7x

------------------------------------------------

2025-03-18

#reports #INSE
@ gaming

[Inspired Entertainment](https://eninvs.com/all.php?name=INSE) (Electronic Gaming and Multimedia) reported for 2024 q4
(2025-03-17, Before Market Open):

- Revenue +5.1% YoY (vs -20.4% in previous quarter and historical rate +23.3%)
- EBITDA +25% YoY (vs +4.5% in previous quarter and historical rate +26.7%)
- EBITDA margin 30.1% increased compared to 25.3% same period last year
- Net Debt decreased by $18 mln over the past reporting period (6.9% of market cap)
- FCF (LTM) -$0 bln (negative), 18.8% of market cap
- EV/EBITDA multiple is 7.5x compared to historical level (75th percentile) of 8.2x
- EV/Sales multiple is 1.9x

At the opening of the session the share price went up +6.3% vs S&P500 -0.1%

------------------------------------------------

2025-03-18

#reports #QFIN
@ china , @ finance-and-technology ,

[360 DigiTech](https://eninvs.com/all.php?name=QFIN) (Credit Services) reported for 2024 q4
(2025-03-17, After Market Close):

- Revenue -3% YoY (vs +6.1% in previous quarter and historical rate -1.8%)
- Net Income +67.9% YoY (vs +64.1% in previous quarter and historical rate +4.3%)
- Net Income margin 42.7% increased compared to 24.6% same period last year
- P/E multiple is 16x compared to historical level (75th percentile) of 10.8x
- P/S multiple is 5.7x
- Price to book: 4.4x

At the opening of the session the share price went up +1.5% vs S&P500 -0.4%

------------------------------------------------

2025-03-18

#reports #CBAT

[CBAK Energy Technology](https://eninvs.com/all.php?name=CBAT) (Electrical Equipment and Parts) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182308)
(2025-03-17, Before Market Open):

- Revenue +9.3% YoY (vs -22.4% in previous quarter and historical rate +55.0%)
- EBITDA margin -8.5% decreased compared to -5.6% same period last year
- Net Debt decreased by $20 mln over the past reporting period (26.2% of market cap)
- FCF (LTM) -$0 bln (negative), 7.8% of market cap
- EV/EBITDA multiple is 5.7x compared to historical level (75th percentile) of 56.5x
- EV/Sales multiple is 0.5x

At the opening of the session the share price went down -5.9% vs S&P500 -0.1%

------------------------------------------------

2025-03-18

#reports #ATNI

[ATN International](https://eninvs.com/all.php?name=ATNI) (Telecommunications company) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182364)
(2025-03-04, After Market Close):

- Revenue +266.3% YoY (vs -6.8% in previous quarter and historical rate +35.6%)
- EBITDA -22% YoY (vs -97.7% in previous quarter and historical rate +17.1%)
- EBITDA margin 4.4% decreased compared to 20.6% same period last year
- Net Debt increased by $20 mln over the past reporting period (5.7% of market cap)
- FCF (LTM) +$0 bln (positive), 0.6% of market cap
- EV/EBITDA multiple is 11.9x compared to historical level (75th percentile) of 9.8x
- EV/Sales multiple is 0.9x

At the opening of the session the share price went up +3.0% vs S&P500 -0.4%

------------------------------------------------

2025-03-18

#reports #AKYA

[Akoya Biosciences, Inc.](https://eninvs.com/all.php?name=AKYA) (Medical Instruments and Supplies) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182307)
(2025-03-17, After Market Close):

- Revenue -19.2% YoY (vs -24.0% in previous quarter and historical rate +31.4%)
- EBITDA margin -23.8% increased compared to -30.8% same period last year
- EV/Sales multiple is 1.6x

------------------------------------------------

2025-03-18

#reports #AGEN

[Agenus](https://eninvs.com/all.php?name=AGEN) (Biotechnology) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182323)
(2024-08-08, Before Market Open):

- Revenue -67.9% YoY (vs +4.2% in previous quarter and historical rate +26.9%)
- EBITDA margin -85.2% decreased compared to 1.2% same period last year
- Net Debt increased by $249 mln over the past reporting period (35.5% of market cap)
- FCF (LTM) +$0.3 bln (positive), 40.0% of market cap
- EV/Sales multiple is 9.6x

At the opening of the session the share price went up +0.8% vs S&P500 +1.0%

------------------------------------------------

2025-03-15

#reports #FRAF

[Franklin Financial Services Corporation](https://eninvs.com/all.php?name=FRAF) (Banks — Regional) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182299)
(2023-04-25, Before Market Open):

- Revenue -51.6% YoY (vs +7.1% in previous quarter and historical rate +5.7%)
- Net Income -236.4% YoY (vs 0.0% in previous quarter)
- Net Income margin -100.0% decreased compared to 35.5% same period last year
- P/S multiple is 2.7x
- Price to book: 1.1x

At the opening of the session the share price went up +0.5%

------------------------------------------------

2025-03-15

#reports #LI
@ china , @ electric-vehicles

[Li Auto](https://eninvs.com/all.php?name=LI) (Vehicles manufacturer) reported for 2024 q4
(2025-03-14, Before Market Open):

- Revenue +3.2% YoY (vs +28.6% in previous quarter and historical rate +81.0%)
- EBITDA +18.8% YoY (vs +45.5% in previous quarter and historical rate +51.9%)
- EBITDA margin 9.1% increased compared to 7.9% same period last year
- Net Debt decreased by $335 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) +$0.6 bln (positive), 2.4% of market cap
- EV/EBITDA multiple is 19x compared to historical level (75th percentile) of 39.3x
- EV/Sales multiple is 1.1x

At the opening of the session the share price went down -3.8% vs S&P500 +0.8%

------------------------------------------------

2025-03-15

#reports #RERE

[ATRenew Inc.](https://eninvs.com/all.php?name=RERE) (Internet Retail) reported for 2024 q4:

- Revenue +23.2% YoY (vs +30.4% in previous quarter and historical rate +22.7%)
- EBITDA margin -1.1% increased compared to -3.4% same period last year
- Net Debt decreased by $81 mln over the past reporting period (14.9% of market cap)
- FCF (LTM) -$0.1 bln (negative), 10.5% of market cap
- EV/Sales multiple is 0.1x

------------------------------------------------

2025-03-15

#reports #MRC

[MRC Global](https://eninvs.com/all.php?name=MRC) (Pipelines and components manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182256)
(2025-03-03, After Market Close):

- Revenue -25% YoY (vs -10.2% in previous quarter and historical rate +5.3%)
- EBITDA -42.1% YoY (vs -28.4% in previous quarter and historical rate +57.1%)
- EBITDA margin 3.8% decreased compared to 4.9% same period last year
- Net Debt decreased by $579 mln over the past reporting period (60.3% of market cap)
- FCF (LTM) +$0.2 bln (positive), 17.3% of market cap
- EV/EBITDA multiple is 8.8x compared to historical level (75th percentile) of 10x
- EV/Sales multiple is 0.5x

At the opening of the session the share price went down -1.6% vs S&P500 -0.3%

------------------------------------------------

2025-03-15

#reports #HSON

[Hudson Global](https://eninvs.com/all.php?name=HSON) (Staffing and Employment Services) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182255)
(2025-03-14, Before Market Open):

- Revenue +202.9% YoY (vs -5.1% in previous quarter and historical rate +13.3%)
- EBITDA margin -2.9% has not changed compared to -2.9% same period last year
- Net Debt increased by $15 mln over the past reporting period (50.0% of market cap)
- FCF (LTM) -$0 bln (negative), 20.0% of market cap
- EV/Sales multiple is 0.1x

At the opening of the session the share price went up +0.9% vs S&P500 +0.8%

------------------------------------------------

2025-03-15

#reports #GOGO

[Gogo](https://eninvs.com/all.php?name=GOGO) (Telecom Services) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182254)
(2025-03-14, Before Market Open):

- Revenue 0% YoY (vs +3.1% in previous quarter and historical rate +7.2%)
- EBITDA -83.3% YoY (vs -39.5% in previous quarter and historical rate -15.0%)
- EBITDA margin 5.1% decreased compared to 30.6% same period last year
- Net Debt increased by $378 mln over the past reporting period (43.1% of market cap)
- FCF (LTM) +$0 bln (positive), 3.6% of market cap
- EV/EBITDA multiple is 18.7x compared to historical level (75th percentile) of 15.4x
- EV/Sales multiple is 4.3x

At the opening of the session the share price went up +10.3% vs S&P500 +0.8%

------------------------------------------------

2025-03-15

#reports #BKE

[The Buckle](https://eninvs.com/all.php?name=BKE) (Apparel Retail) reported for 2024 q4
(2025-03-14, Before Market Open):

- Revenue -0.8% YoY (vs -3.0% in previous quarter and historical rate -2.1%)
- EBITDA 0% YoY (vs -15.4% in previous quarter and historical rate -10.2%)
- EBITDA margin 27.2% increased compared to 27.0% same period last year
- Net Debt increased by $37 mln over the past reporting period (2.1% of market cap)
- FCF (LTM) +$0 bln (positive), 1.1% of market cap
- EV/EBITDA multiple is 6.8x compared to historical level (75th percentile) of 6.9x
- EV/Sales multiple is 1.5x

At the opening of the session the share price went up +6.2% vs S&P500 +0.8%

------------------------------------------------

2025-03-15

#reports #FUTU
@ china , @ saas

[Futu](https://eninvs.com/all.php?name=FUTU) (Capital Markets) reported for 2024 q4
(2025-03-13, Before Market Open):

- Revenue +87.8% YoY (vs +30.8% in previous quarter and historical rate +28.4%)
- Net Income +115.2% YoY (vs +22.3% in previous quarter and historical rate +33.1%)
- Net Income margin 42.2% increased compared to 36.8% same period last year
- P/E multiple is 24.9x compared to historical level (75th percentile) of 20.9x
- P/S multiple is 10x
- Price to book: 4.3x

At the opening of the session the share price went down -2.8% vs S&P500 -0.1%

------------------------------------------------

2025-03-15

#reports #DOYU
@ china

[DouYu International](https://eninvs.com/all.php?name=DOYU) ( Entertainment services provider) reported for 2024 q4
(2024-05-15, Before Market Open):

- Revenue -14.8% YoY (vs -18.8% in previous quarter and historical rate -23.6%)
- EBITDA margin -11.5% decreased compared to -5.5% same period last year
- Net Debt increased by $147 mln over the past reporting period (5.2% of market cap)
- FCF (LTM) -$0.3 bln (negative), 12.0% of market cap
- EV/Sales multiple is 4.5x

------------------------------------------------

2025-03-14

#reports #XPOF

[Xponential Fitness, Inc.](https://eninvs.com/all.php?name=XPOF) (Leisure) reported for 2024 q4
(2025-03-13, After Market Close):

- Revenue -7.8% YoY (vs 0.0% in previous quarter and historical rate +30.6%)
- EBITDA -771.4% YoY (vs -116.7% in previous quarter and historical rate -4.9%)
- EBITDA margin -56.6% decreased compared to 7.8% same period last year
- Net Debt increased by $1.4 bln since the start of the year (368.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 20.0% of market cap
- EV/Sales multiple is 8.3x

------------------------------------------------

2025-03-14

#reports #TCX

[Tucows](https://eninvs.com/all.php?name=TCX) (Domain name registrar) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182249)
(2025-02-13, After Market Close):

- Revenue +6.9% YoY (vs +5.7% in previous quarter and historical rate +6.1%)
- EBITDA margin -20.4% decreased compared to -6.9% same period last year
- Net Debt increased by $307 mln over the past reporting period (149.0% of market cap)
- FCF (LTM) -$0 bln (negative), 11.6% of market cap
- EV/Sales multiple is 1.3x

At the opening of the session the share price went up +0.2% vs S&P500 +0.1%

------------------------------------------------

2025-03-14

#reports #MNTK

[Montauk Renewables, Inc.](https://eninvs.com/all.php?name=MNTK) (Utilities — Diversified) reported for 2024 q4
(2025-03-12, After Market Close):

- Revenue 0% YoY (vs +17.9% in previous quarter and historical rate +31.8%)
- EBITDA -106.2% YoY (vs +31.8% in previous quarter and historical rate +44.8%)
- EBITDA margin -14.3% decreased compared to 232.1% same period last year
- Net Debt increased by $11 mln over the past reporting period (3.1% of market cap)
- FCF (LTM) -$0 bln (negative), 3.7% of market cap
- EV/EBITDA multiple is 9.3x compared to historical level (75th percentile) of 29.8x
- EV/Sales multiple is 2.1x

At the opening of the session the share price went down -4.9% vs S&P500 -0.1%

------------------------------------------------

2025-03-14

#reports #MBCN

[Middlefield Banc](https://eninvs.com/all.php?name=MBCN) (Banks — Regional) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182245)
(2025-01-23, After Market Close):

- Revenue 0% YoY (vs -6.3% in previous quarter and historical rate +4.0%)
- Net Income +25% YoY (vs -50.0% in previous quarter and historical rate +10.9%)
- Net Income margin 33.3% increased compared to 26.7% same period last year
- P/E multiple is 10x compared to historical level (75th percentile) of 12x
- P/S multiple is 2.5x
- Price to book: 0.7x

At the opening of the session the share price went up +0.6% vs S&P500 +0.3%

------------------------------------------------

2025-03-14

#reports #LCUT

[Lifetime Brands](https://eninvs.com/all.php?name=LCUT) (Furnishings, Fixtures and Appliances) reported for 2024 q4
(2025-03-13, Before Market Open):

- Revenue +5.9% YoY (vs -4.2% in previous quarter and historical rate -7.4%)
- EBITDA +14.3% YoY (vs -27.8% in previous quarter and historical rate +30.8%)
- EBITDA margin 11.2% increased compared to 10.3% same period last year
- Net Debt decreased by $23 mln over the past reporting period (22.5% of market cap)
- FCF (LTM) -$0 bln (negative), 1.0% of market cap
- EV/EBITDA multiple is 6.5x compared to historical level (75th percentile) of 22.9x
- EV/Sales multiple is 0.5x

At the opening of the session the share price went up +8.1% vs S&P500 -0.1%

------------------------------------------------

2025-03-14

#reports #KRT

[Karat Packaging Inc.](https://eninvs.com/all.php?name=KRT) (Packaging and Containers) reported for 2024 q4
(2025-03-13, After Market Close):

- Revenue +6.3% YoY (vs +6.6% in previous quarter and historical rate +5.9%)
- EBITDA +42.9% YoY (vs 0.0% in previous quarter and historical rate +15.9%)
- EBITDA margin 9.8% increased compared to 7.3% same period last year
- EV/EBITDA multiple is 11.2x compared to historical level (75th percentile) of 10.9x
- EV/Sales multiple is 1.3x

------------------------------------------------

2025-03-14

#reports #EVCM

[EverCommerce Inc.](https://eninvs.com/all.php?name=EVCM) (Software — Infrastructure) reported for 2024 q4
(2025-03-13, After Market Close):

- Revenue +3.6% YoY (vs +0.6% in previous quarter and historical rate +10.9%)
- EBITDA +23.1% YoY (vs 0.0% in previous quarter and historical rate +37.6%)
- EBITDA margin 18.3% increased compared to 15.4% same period last year
- Net Debt decreased by $35 mln over the past reporting period (2.1% of market cap)
- FCF (LTM) +$0 bln (positive), 1.0% of market cap
- EV/EBITDA multiple is 18.4x compared to historical level (75th percentile) of 29.8x
- EV/Sales multiple is 2.9x

------------------------------------------------

2025-03-14

#reports #VERI

[Veritone](https://eninvs.com/all.php?name=VERI) (Software — Infrastructure) reported for 2024 q4
(2025-03-13, After Market Close):

- Revenue -35.3% YoY (vs -37.1% in previous quarter and historical rate +8.0%)
- EBITDA margin -59.1% decreased compared to -35.3% same period last year
- Net Debt decreased by $28 mln over the past reporting period (32.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 79.3% of market cap
- EV/Sales multiple is 1.8x

------------------------------------------------

2025-03-14

#reports #TACT

[TransAct Technologies](https://eninvs.com/all.php?name=TACT) (Computer Hardware) reported for 2024 q4
(2025-03-13, After Market Close):

- Revenue -23.1% YoY (vs -35.3% in previous quarter and historical rate +15.7%)
- Net Debt decreased by $10 mln over the past reporting period (27.8% of market cap)
- FCF (LTM) -$0 bln (negative), 5.6% of market cap
- EV/EBITDA multiple is 26x compared to historical level (75th percentile) of 14.3x
- EV/Sales multiple is 0.6x

------------------------------------------------

2025-03-14

#reports #SOHO

[Sotherly Hotels](https://eninvs.com/all.php?name=SOHO) (REIT — Hotel and Motel) reported for 2024 q4
(2025-03-13, Before Market Open):

- Revenue +4.8% YoY (vs +5.1% in previous quarter and historical rate +14.6%)
- EBITDA 0% YoY (vs +16.7% in previous quarter)
- EBITDA margin 20.5% decreased compared to 21.4% same period last year
- EV/EBITDA multiple is 0.4x compared to historical level (75th percentile) of 1.1x
- EV/Sales multiple is 0.1x

At the opening of the session the share price went down -1.3% vs S&P500 -0.1%

------------------------------------------------

2025-03-14

#reports #RGNX

[REGENXBIO](https://eninvs.com/all.php?name=RGNX) (Developer of viral gene therapy) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182215)
(2025-03-13, After Market Close):

- Revenue -4.5% YoY (vs -17.2% in previous quarter and historical rate -11.8%)
- EBITDA margin -238.1% increased compared to -272.7% same period last year
- Net Debt increased by $18 mln over the past reporting period (5.4% of market cap)
- FCF (LTM) -$0 bln (negative), 4.5% of market cap
- EV/Sales multiple is 2.2x

------------------------------------------------

2025-03-14

#reports #PD

[PagerDuty](https://eninvs.com/all.php?name=PD) (Software provider) reported for 2024 q4
(2025-03-13, After Market Close):

- Revenue +9% YoY (vs +9.2% in previous quarter and historical rate +17.1%)
- EBITDA margin -0.8% increased compared to -20.7% same period last year
- Net Debt decreased by $23 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 6.1% of market cap
- EV/Sales multiple is 2.8x

------------------------------------------------

2025-03-14

#reports #FNWB

[First Northwest Bancorp](https://eninvs.com/all.php?name=FNWB) (Banks — Regional) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182213)
(2025-01-29, Before Market Open):

- Revenue 0% YoY (vs -6.7% in previous quarter and historical rate -7.2%)
- Net Income margin 14.3% increased compared to -35.7% same period last year
- P/S multiple is 1.8x
- Price to book: 0.6x

At the opening of the session the share price went down -0.6% vs S&P500 -0.2%

------------------------------------------------

2025-03-14

#reports #ASPS

[Altisource Portfolio Solutions](https://eninvs.com/all.php?name=ASPS) (Mortgage Finance) reported for 2024 q4
(2025-03-13, Before Market Open):

- Revenue +20.6% YoY (vs +13.9% in previous quarter and historical rate -2.7%)
- Net Income margin -22.0% increased compared to -38.2% same period last year
- P/S multiple is 0.2x
- Price to book: -0.2x

At the opening of the session the share price went down -2.7% vs S&P500 -0.1%

------------------------------------------------

2025-03-14

#reports #AKBA

[Akebia Therapeutics](https://eninvs.com/all.php?name=AKBA) (Biotechnology) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182211)
(2025-03-13, Before Market Open):

- Revenue -17.9% YoY (vs -11.9% in previous quarter and historical rate -8.7%)
- EBITDA -320% YoY (vs -100.0% in previous quarter)
- EBITDA margin -23.9% decreased compared to 8.9% same period last year
- Net Debt decreased by $18 mln over the past reporting period (5.6% of market cap)
- FCF (LTM) -$0 bln (negative), 2.8% of market cap
- EV/Sales multiple is 2.1x

At the opening of the session the share price went down -6.7% vs S&P500 -0.1%

Switch to company model in classical logic    *